ConductScience.org, home

Comparison · NCT00071032-43d0a0a3

Liberal (10 g/dL) Transfusion Strategy vs Restrictive Strategy: Disposition Status (i.e., Nursing Home Placement)

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Liberal (10 g/dL) Transfusion Strategy vs Restrictive Strategy: Disposition Status (i.e., Nursing Home Placement). Trial comparisons, record NCT00071032-43d0a0a3. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00071032-43d0a0a3

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1380.1180.16wilson
Risk in group 20.1610.1390.185wilson
Risk difference, group 1 minus group 2-0.0233-0.05460.00801newcombe hybrid score
Risk ratio, group 1 over group 20.8550.6931.06log
Odds ratio, group 1 over group 20.8320.651.07log
Number needed to treat, for one fewer participant with the outcome on Liberal (10 g/dL) Transfusion Strategy than on Restrictive Strategy42.9from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Liberal (10 g/dL) Transfusion StrategyTransfusion strategy that maintains postoperative Hgb levels \>= 10 g/dL137996OG000
Group 2Restrictive StrategySymptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL1611,001OG001

Outcome

Type
SECONDARY
Title
Disposition Status (i.e., Nursing Home Placement)
Description
Nursing Home Residence
Time frame
60 days
Population

Source ClinicalTrials.gov

Trial

Title
Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease
NCT number
NCT00071032
Phases
PHASE3
Conditions
Anemia, Hematologic Diseases, Cardiovascular Diseases, Heart Diseases, Myocardial Infarction, Thromboembolism, Pneumonia, Cerebrovascular Accident
Interventions
Liberal (10 g/dL) Transfusion Strategy, Restrictive (Symptomatic) Transfusion Strategy
Lead sponsor
Rutgers, The State University of New Jersey
Results first posted
2014-08-28

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00071032-43d0a0a3